Difficulty: Medium
Average Score: 65%
Practice
A main determinant of bioavailability (F) following oral administration is
Correct answer
A
Rationale
In pharmacology, bioavailability (F) is a critical concept that refers to the fraction of an administered dose of a drug that reaches systemic circulation in an unchanged form. The main determinant of bioavailability following oral administration is the hepatic extraction ratio (E), making option A the correct answer.
Hepatic extraction ratio (E) is the fraction of drug removed by the liver during the first pass. It is a crucial factor in determining the bioavailability of orally administered drugs because drugs must pass through the liver before reaching systemic circulation. Drugs with high hepatic extraction ratios undergo significant metabolism in the liver, leading to low bioavailability.
Elimination rate constant (Ke) is a parameter used to describe the rate at which a drug is removed from the body. While Ke is important in determining the half-life of a drug, it is not the main determinant of bioavailability after oral administration.
Bioequivalence (option C) refers to the similarity in the rate and extent of drug absorption between different formulations of the same drug. While bioequivalence is essential for generic drugs, it is not the main determinant of bioavailability after oral administration.
Volume of distribution (option D) is a pharmacokinetic parameter that describes the extent of drug distribution in the body relative to the drug concentration in the plasma. While volume of distribution is crucial for understanding how a drug is distributed in the body, it is not the main determinant of bioavailability after oral administration.
Understanding the main determinants of bioavailability is crucial for healthcare professionals to optimize drug therapy outcomes. Knowledge of hepatic extraction ratio and other factors influencing bioavailability helps in dosing regimen adjustments and predicting the efficacy of orally administered drugs.
Hepatic extraction ratio (E) is the fraction of drug removed by the liver during the first pass. It is a crucial factor in determining the bioavailability of orally administered drugs because drugs must pass through the liver before reaching systemic circulation. Drugs with high hepatic extraction ratios undergo significant metabolism in the liver, leading to low bioavailability.
Elimination rate constant (Ke) is a parameter used to describe the rate at which a drug is removed from the body. While Ke is important in determining the half-life of a drug, it is not the main determinant of bioavailability after oral administration.
Bioequivalence (option C) refers to the similarity in the rate and extent of drug absorption between different formulations of the same drug. While bioequivalence is essential for generic drugs, it is not the main determinant of bioavailability after oral administration.
Volume of distribution (option D) is a pharmacokinetic parameter that describes the extent of drug distribution in the body relative to the drug concentration in the plasma. While volume of distribution is crucial for understanding how a drug is distributed in the body, it is not the main determinant of bioavailability after oral administration.
Understanding the main determinants of bioavailability is crucial for healthcare professionals to optimize drug therapy outcomes. Knowledge of hepatic extraction ratio and other factors influencing bioavailability helps in dosing regimen adjustments and predicting the efficacy of orally administered drugs.